NCT02531425
- Conditions
- Breast Diseases, Breast Neoplasms, ER-Negative PR-Negative HER2-Negative Breast Cancer, +5 more
- Locations
-
- Stanford University Stanford, California, United States
Clinical trial condition
ER-Negative PR-Negative HER2-Negative Breast Cancer
Explore clinical trials studying ER-Negative PR-Negative HER2-Negative Breast Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies